4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002495
Chief Financial Officer bought 3,100 shares at $3.20 ($9,920)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-17 | Purchase : show line 1 in the form | +3,100 | $3.20 | $9,920 | 9,251 | D |
| Open-market purchases · 3,100 sh · avg $3.20 · $9,920 | ||||||
Loading xslF345X04/ownership.xml…